BMRN
BMRN
$57.46
per share, on-chain
What BMRN does
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
- Industry
- Healthcare
- Website
- biomarin.com
Ways to own BMRN
There's one version of this stock on Firstshare.
OndoBMRNonOur pick
Wider choice. Usually $20 minimum, and it can cost more when New York is closed.
$57.46
Closed until New York opens
Price check
What a slice looks like
$10.00 buys you 0.17 of one BMRN share.
That's 17.4% of one share. Small, but it's yours, and it moves with the real price. One share costs $57.46.